UTI Healthcare Fund
☆ Add to Watchlist
More Options
Business Overview
UTI Healthcare Fund is a specialized mutual fund designed for investors looking to capitalize on the growth potential of the healthcare sector in India. This fund focuses on companies involved in pharmaceuticals, biotechnology, and healthcare services, making it ideal for those seeking long-term capital appreciation. With a robust management team and a commitment to research-driven investment strategies, UTI Healthcare Fund aims to deliver consistent returns while mitigating risks associated with the volatile healthcare market.
- Targeted investment in the healthcare sector
- Expert management team with extensive experience
- Focus on long-term capital appreciation
- Diversification across pharmaceuticals and healthcare services
- Research-driven strategies to optimize returns
Investment Thesis
UTI Healthcare Fund presents a compelling investment opportunity, backed by a credible promoter group and a strong focus on digital healthcare services. With an expanding growth runway in the digital sector and attractive valuations compared to peers, this fund is poised for significant upside potential.
- Strong promoter group with a proven track record in asset management.
- Robust growth potential in digital healthcare services, catering to evolving consumer needs.
- Attractive valuations compared to industry peers, offering a favorable entry point.
- Focus on innovation and technology to enhance service delivery and operational efficiency.
- Commitment to sustainable investing, aligning with long-term investor interests.
Opportunity vs Risk
- Growing healthcare sector in India
- Rising demand for health services
- Government support for healthcare initiatives
- Potential for long-term capital appreciation
- Regulatory changes affecting healthcare
- Market volatility impacting returns
- High competition in healthcare sector
- Economic downturns affecting funding
-
10BusinessHighHealthcare sector is future-ready with a clear growth model.
-
10GrowthHighConsistent revenue growth observed over the last few years.
-
10ProfitabilityHighROE and ROCE are above industry averages, but OCF is slightly lower.
-
8ValuationHighP/E and P/B ratios are reasonable compared to peers.
-
7BalanceHighDebt levels are manageable with good liquidity.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth catalysts are present, but execution risks remain.
-
5TechnicalsGoodMarket sentiment is neutral with moderate liquidity.